QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of a price target for MEDTRONIC PLC....
On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was trading at $84.85....
On May 20, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC with a price of $85.66. Fast forward to July 11, 2025, and the stock had surged to $89....
On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....
QuantWave's forecast for MEDTRONIC PLC stock has successfully achieved its price target, resulting in a profit of 6.79%. The forecast signal date was 2025-05-21, with a price of 83....
QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....
On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....
On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC at a price of 82.76 $....
In an impressive display of accuracy, QuantWave, the automated forecasting platform, has successfully reached its price target forecast for MEDTRONIC PLC....
Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....
Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease....
AbbVie Inc. (NYSE:ABBV) recently released the Phase 3 data for its investigational drug, tavapadon, for the treatment of Parkinson's disease....
Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments....
GSK PLC's antibody-drug conjugate (ADC) has recently been granted the breakthrough therapy designation by the US Food and Drug Administration (FDA)....
Medical technology company Medtronic PLC (MDT) has announced that it has received CE Mark approval for its revolutionary BrainSense Adaptive deep brain stimulation (DBS) system....